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Abstract
Background: Two of our long term efforts are to discover compounds with synergistic antifungal activity from metabolites
of marine derived microbes and to optimize the production of the interesting compounds produced by microorganisms. In
this respect, new applications or mechanisms of already known compounds with a high production yield could be
continually identified. Surfactin is a well-known lipopeptide biosurfactant with a broad spectrum of antimicrobial and
antiviral activity; however, there is less knowledge on surfactin’s antifungal activity. In this study, we investigated the
synergistic antifungal activity of C15-surfactin and the optimization of its production by the response surface method.
Methodology/Principal Findings: Using a synergistic antifungal screening model, we found that the combination of C15-
surfactin and ketoconazole (KTC) showed synergistic antifungal effect on Candida albicans SC5314 when the concentrations
of C15-surfactin and KTC were 6.25 mg/mL and 0.004 mg/mL, respectively. These concentrations were lower than their own
efficient antifungal concentrations, which are .100 mg/mL and 0.016 mg/mL, respectively. The production of C15-surfactin
from Bacillus amyloliquefaciens was optimized by the response surface methodology in shaker flask cultivation. The Plackett-
Burman design found sucrose, ammonium nitrate and NaH2PO4.2H2O to have significant effects on C15-surfactin
production. The optimum values of the tested variables were 21.17 g/L sucrose, 2.50 g/L ammonium nitrate and 11.56 g/L
NaH2PO4?2H2O. A production of 134.2 mg/L, which were in agreement with the prediction, was observed in a verification
experiment. In comparison to the production of original level (88.6 mg/L), a 1.52-fold increase had been obtained.
Conclusion/Significance: This work first found that C15-surfactin was an efficient synergistic antifungal agent, and
demonstrated that response surface methodology was an effective method to improve the production of C15-surfactin.
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Introduction
Biosurfactants (e.g., glycolipids, phospholipids, lipoproteins or
lipopeptides, polymeric compounds, mycolic acids, and lipopoly-
saccharides) are a heterogeneous group of secondary metabolites
with surface active properties, and described to be synthesized by a
variety of bacteria [1,2]. Surfactin is an important biosurfactant
with superior surface activity and belongs to a group of cyclic
lipoheptapeptides containing beta-hydroxyl fatty acids and D2/L-
amino acid residues [3,4]. Surfactins are mainly composed of three
components: C13-surfactin, C14-surfactin, and C15-surfactin. Of
those C15-surfactin has the highest: (1) surface activity, about 1000
times higher than the traditional chemical surfactant sodium
dodecyl sulfate (SDS) [5,6], and (2) hemolytic activity [7,8]. C15-
surfactin also has other activites, including anti-tumor, anti-
microbial, and anti-mycoplasma functions [9,10,11,12,13]. Its
amphiphilic structural characteristics contribute to its unique
ability to interact with cell membranes and macromolecules such
as enzymes and lipopolysaccharides (LPSs). Specifically, C15-
surfactin non-competitively inhibits the activity of the alkaline
phosphatase due to the chelating action by the free carboxyl
groups of the Asp and Glu residues [14]. The binding of C15-
surfactin with LPS inhibits the activity of LPS, which leads to the
interruption of the LPS induced pathway [15,16]. These
properties demonstrate the commercial importance of C15-
surfactin, specifically in the biomedical science and pharmaceu-
tical fields [17,18].
Yet, even with significant investigations on C15-surfactin,
commercial production has been impeded by its high production
cost due to low product yield. To address this problem, the
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methods for the efficient production of C15-surfactin is of
particular importance. We have constructed a high quality
microbial natural product library, from which Bacillus velezensis
strain H3, Saccharopolyspora sp. A9 and Streptomyces sp. B3 have been
recently identified to be biosurfactant producers [19,20,21]. This
microbial natural product library has been a rich source for the
discovery of C15-surfactin producing strains.
The goal of the current research is to demonstrate an efficient
method for the production of C15-surfactin and the novel
synergistic antifungal effects of surfactins with ketoconazole against
Candida albicans. On the basis of this discovery, the medium
composition was optimized to enhance the productivity of C15-
surfactin by a novel marine derived Bacillus amyloliquefaciens strain
MB199. This was achieved by combining the Plackett-Burman
design (PBD), the steepest ascent design, and the central composite
rotatable design (CCRD) of response surface methodology (RSM).
This study will provide promising results for the development of
new antifungal drug combination.
Materials and Methods
Synergistic Antifungal Assay
A synergistic antifungal assay was performed with surfactins
according to the previously described method [22]. Briefly, Candida
albicans SC5314 cells (,1610
4) were inoculated in a final volume
of 80 mL mixture of RPMI 1640 medium, 8% Alamar blue
(BioSource International, Camarillo, CA), and 2 mL drugs in each
well of flat bottom, 96-well microtiter plates (VWR, West Chester,
PA). Candida albicans SC5314 cells was incubated overnight at
35uC, 80% humidity, and 5% CO2. Surfactins and KTC were
prepared as stock solutions in DMSO. Growths of fungus cells
were affected in the presence and absence of a sub-clinical
concentration of 0.004 mg/mL ketoconazole. To determine the
percentage of remaining viable cells, the fluorescence was
measured at an excitation wavelength (Ex) of 544 nm and an
emission wavelength (Em) of 590 nm using an EnVision 2103
multilabel reader (PerkinElmer, USA).
To determine the Minimum inhibitory concentrations (MICs),
concentrations of surfactins were diluted by a serial 2-fold
dilution method according to a modified protocol from the
Clinical and Laboratory Standards Institute (formerly National
Committee for Clinical Laboratory Standards) M-38A and M-
27A2 methods. The MIC was defined as a concentration of an
antimicrobial that prevented 100% of cell growth during 18-hr
incubation at 35uC.
To determine whether drug interaction was synergistic,
additive, or antagonistic for the combination of surfactins and
KTC, fractional inhibitory concentration index (FICI) was used.
FICI= (MIC drug A in combination/MIC drug A alone) + (MIC drug B in
combination/MIC drug B alone) [22]. The interaction was defined as
synergistic if the FICI was ,0.50, additive if the FICI was 0.50 to
4.0, and antagonistic if the FICI was .4.0.
Micro-organisms and Culture Medium
Four microbial strains Bacillus sp. MB198, MB245, MB199,
and MB200 were isolated from HuangBo Sea, China and
shown using mass spectrometry to produce surfactins (data not
shown). These strains were screened for the optimum surfactin
producer with the fermentation medium as described in the
following. The seed culture medium for all Bacillus strains was a
Luria Bertani (LB) medium consisting of 5 g/L yeast extract,
Figure 1. The structure of C15-Surfactin.
doi:10.1371/journal.pone.0034430.g001
Table 1. The Plackett-Burman design for screening variables
for C15-surfactin production.
Factors
(g/L) Code
Low
level
(21)
High
level
(+1) Coef* F-value p-value
Sucrose x1 10 30 29.98 26.10 0.0145
NH4NO3 x2 0 4 8.07 17.06 0.0257
K2HPO4?3H2O x4 0.5 6 4.98 6.49 0.0841
NaH2PO4?2H2O x5 5 15 8.55 19.16 0.0221
MgSO4?7H2O x7 00 . 4 20.88 0.20 0.6828
MnCl2?4H2O x8 0 0.004 2.48 1.62 0.2934
Yeast extract x9 0.05 0.35 24.61 5.57 0.0994
Temperature x10 27 30 1.72 0.78 0.4433
R
2=96.25%, R
2 (adj) =86.25%.
*Coef: coefficient.
doi:10.1371/journal.pone.0034430.t001
Production of Surfactin with Synergistic Activity
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e3443010 g/L NaCl, 10 g/L tryptone, and a pH of 7.2. The
fermentation medium used for shaker flask cultivation contained
20 g/L carbon source, 2.0 g/L nitrogen source, 3.0 g/L
K2HPO4?3H2O, 10 g/L NaH2PO4?2H2O, 0.2 g/L
MgSO4?7H2O, 0.002 g/L MnCl2?4H2O, and 0.2 g/L yeast
extract. Carbon source and nitrogen source were arranged
according to the description of the following section. Two
milliliter of seed medium was transferred to a 250 mL
Erlenmeyer flask containing 50 mL fermentation medium and
incubated at 28uC for 48 h on a rotary shaker (200 rpm).
Selection of Optimum Carbon Source and Nitrogen
Source
To optimize the carbon source, glucose, sucrose, galactose,
maltose, sucrose, glycerol, mannitol, soluble starch, and dextrin
were evaluated. To optimize the nitrogen source, ammonium
Table 2. The Placket-Burman design variables (in coded levels) with C15-surfactin yield as response.
Run Variable levels
Yield of C15-surfactin
(mg/L)
x1 x2 x3 x4 x5 x6 x7 x8 x9 x10 x11
11 21 11121 21 211 21 1 12.7060.88
2 211 211 1 21 11121 21 53.0060.29
31 211 1 21 11121 21 21 15.1960.72
4 11121 21 211 211 1 21 3.9260.42
5 21 21 21 21 21 21 21 21 21 21 21 14.5560.90
61 1 21 21 211 211 1 21 1 12.7360.99
7 21 211 211 1 21 11121 38.2761.45
8 211 1 211 1 1 21 21 21 1 51.7261.69
91 21 21 211 211 1 21 1 1 17.8861.01
10 21 21 211 211 1 21 1 1 1 23.2260.99
11 1 1 211 1 1 21 21 211 21 47.9360.80
12 21 11121 21 211 21 1 1 49.3160.18
doi:10.1371/journal.pone.0034430.t002
Table 3. Design and results of CCD.
Run Sucrose NH4NO3 NaH2PO4?2H2O Yield of C15-Surfactin (mg/L)
Code X1 X1 (g/L) Code X2 X2 (g/L) Code X3 X3 (g/L)
1 21 17 1 2.5 1 14 118.0861.23
2 0 20 0 2.0 21.68 17 45.5660.42
3 1 23 1 2.5 1 14 130.41612.94
4 0 20 0 2.0 1.68 17 100.6061.26
5 0 20 1.68 2.8 0 10 128.9662.38
6 1 23 1 2.5 21 6 106.7065.91
71 2 3 21 1.5 21 6 49.8461.71
80 2 0 21.68 1.2 0 10 96.0765.94
9 21.68 15 0 2.0 0 10 131.3960.87
10 1.68 25 0 2.0 0 10 98.41625.73
11 0 20 0 2.0 0 10 126.2763.13
12 0 20 0 2.0 0 10 121.3361.85
13 21 17 1 2.5 21 6 102.6863.83
14 0 20 0 2.0 0 10 119.3660.53
15 211 7 21 1.5 21 6 85.18610.36
16 1 23 21 1.5 1 14 106.2366.41
17 0 20 0 2.0 0 10 117.4967.01
18 211 7 21 1.5 1 14 107.4964.82
19 0 20 0 2.0 0 10 115.1465.95
20 0 20 0 2.0 0 10 124.47615.67
doi:10.1371/journal.pone.0034430.t003
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peptone, casein acid hydrolysate, urea, and glutamic sodium were
evaluated. C15-surfactin (MW1035, Fig. 1) production was
calculated by the method described in the section of ‘‘Analytical
methods’’.
16S rDNA Sequence Analysis
Genomic DNA of Bacillus sp. was extracted using a TIANamp
Bacteria DNA Kit (DP302, Tiangen Biotech (Beijing) Co., LTD.,
Beijing, China). The PCR method was performed according to the
methods described previously [21]. Bacillus strains and calculations
of sequence similarity were carried out using CLUSTAL X1 [23].
A phylogenetic tree was constructed using the neighbor-joining
method and MEGA 4.0 software [24]. The topology of the
phylogenetic tree was evaluated by 1000 bootstrap resampling
replicates [25].
Experimental Design and Data Analysis
The most significant parameters affecting C15-surfactin pro-
duction from Bacillus amyloliquefaciens MB199 were determined
using the Plackett-Burman Design (PBD), as noted in Table 1
(Yeast extract is a good source of nitrogen and metals, so the low
levels of x2,x 7 and x8 could be set as 0). The analysis of C15-
surfactin production was carried out in twelve experiments, each
of which was performed two times (Table 2). Three dummy
variables (x3,x 6 and x11) were studied in 12 experiments to
calculate the standard error. The final result was expressed as the
average value of the two repeated experiments. The variables with
confidence levels above 95% were considered to have significant
effects on C15-surfactin production and were used for further
optimization. Using the trends in the data provided by the results
of the PBD, the experiments were adapted by increasing or
decreasing the concentrations of each variable following the result
of PBD [26]. Finally, a central composite rotatable design was
produced with the values of each variable noted with the design
matrix (Table 3). The low, middle, and high levels of each variable
were designated as 21.68, 21, 0, and 1, 1.68, respectively and a
response surface was produced.
Statistical Analysis
Design Expert (Version 7.0, Stat-Ease Inc., USA) was used to
generate the experimental designs and perform subsequent
regression analysis of the experimental data. The quality of the
polynomial model equation was judged statistically using analysis
of variance (ANOVA) to determine the coefficient of determina-
tion, R
2. The statistical significance was determined using the F-
test and significance of the regression coefficients was determined
using the t-test.
Extraction of Surfactins
Isolation and extraction of surfactins were performed according
to the previously described method [27] with minor modifications.
Briefly, after 48 hours of fermentation 35 mL cell broth was
subjected to centrifugation at 8000 rpm for 5 min to remove the
bacteria cells. The supernatant was then subjected to an acid
precipitation with 6 M HCl by adjusting the pH to 2.0 and
refrigerated at 4uC for 24 h. The precipitant was collected by
centrifugation at 8000 rpm for 5 min followed by 24 h of
lyophilization at 250uC. The lyophilized powder was extracted
with 2 mL methanol for 4 h. Then the methanol extract was
filtered using a 0.45 mm filter.
Table 4. Synergy antifungal screening result
a.
Samples Anti-fungal MICs (mg/mL) Synergistic anti-fungal MICs (mg/mL)
Acid Precipitation
b .100 50
Lipopeptide Mixture
c 50 25
C14-surfactin .100 12.5
C15-surfactin .100 6.25
Cyclosporin A .64 4
aThe MIC of KTC is 0.016 mg/mL. The concentration of KTC in synergy antifungal screening experiment is 0.004 mg/mL, at which KTC does not show antifungal activity.
bAcid precipitation was obtained by centrifugation of cell broth at pH 2.0. It contains C13-surfactin, C14-surfactin, C15-surfactin and other kind of compounds.
cLipopeptide mixture is purified fraction from acid precipitation, and is the mixture of C13-surfactin, C14-surfactin, and C15-surfactin.
doi:10.1371/journal.pone.0034430.t004
Figure 2. Effects of carbon source on the production of C15-surfactin from B. amyloliquefaciens MB199.
doi:10.1371/journal.pone.0034430.g002
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The methanol extraction of surfactin was analyzed using a
HPLC system (Agilent 1100 Series, CA, USA) equipped with an
Agilent XDB C18 column (W 4.6 mm615 cm, 5 mm). The mobile
phase consisted of 90% methanol and 10% water (0.1% TFA).
After loaded with 40 mL filtered methanol extract, and column
was eluted at a flow rate of 1 mL/min. The elution was monitored
by the UV absorbance at 210 nm. C15-surfactin was identified to
be eluted at a retention time of 11.0 min according to LC-MS
results.
Results and Discussion
Synergistic Antifungal Activity of Surfactins
During the process of high throughput screening for the novel
synergic antifungal compound, C14-surfactin and C15-surfactin
were found to be most efficient when compared to the crude
extract-acid precipitation (Table 4). It showed that C14-surfactin
and C15-surfactin had synergistic antifungal activities with KTC
against Candida albicans at 12.5 mg/mL and 6.25 mg/mL, respec-
tively (Table 4). Based on these MIC values, the FICIs of C14-
surfactin and C15-surfactin were less than 0.4 and 0.3 (all of them
were less than 0.5), respectively, so the combination of surfactins
and KTC were synergistic.
KTC is a frequently used antifungal drug (MIC=0.016 mg/
mL), which resulted in two drawbacks. One is the appearance of
the resistant fungi. The other is the side-effect on human being
produced by KTC at an efficient active concentration. So we
design this synergy antifungal model to screen compounds which
can synergize KTC with 1/4MIC (a concentration found to be no
antifungal activity and also less side-effect on the patient). With this
method C15-surfactin was identified to be best synergistic
antifungal agent for KTC. This result not only proved the
efficiency of our synergy screening model, but also highlights the
new application of surfactin as a synergistic antifungal agent of
KTC.
Figure 3. Effects of nitrogen source on the production of C15-surfactin from B. amyloliquefaciens MB199 with sucrose as the carbon
source.
doi:10.1371/journal.pone.0034430.g003
Figure 4. Neighbour-joining phylogenetic tree of B. amyloliquefaciens MB199 constructed by Mega 4.0. Numbers at nodes indicate levels
of bootstrap support (%) based on a neighbour-joining analysis of 1000 resampled datasets; only values .50% are given. NCBI accession numbers are
given in parentheses. Bar, 0.005 nucleotide substitutions per site.
doi:10.1371/journal.pone.0034430.g004
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iturin on its hemolytic activity [28]. However, there is limited
knowledge about the antifungal and synergistic antifungal
activities of this compound. The results of our study showed a
new effect of surfactin when KTC was incorporated. Surfactin has
been known to interact with the cell membrane and disturbs the
membrane’s stability [29,30,31,32]. Among C13-surfactin, C14-
surfactin and C15-surfactin, C15-surfactin was the most effective
compound to interact with membranes because the longer fatty
acid chain induces a greater interfacial activity of surfactins with
the membrane [29]. This performance was helpful to explain our
result that C15-surfactin was more active than C14-surfactin.
Selection of Optimum Carbon Source, Nitrogen Source
The effect of the carbon source on C15-surfactin production of
strain MB199 was given in Fig. 2. The optimum carbon source
was found to be sucrose, which enabled MB199 to reach a
maximum yield of 102.0 mg/L C15-surfactin.
With sucrose as the carbon source, the effect of the nitrogen
source on C15-surfactin production for strain MB199 is given in
Fig. 3. The maximum yield of surfactin (99.6 mg/L) was produced
by the MB199 strain with ammonium nitrate used as the nitrogen
source.
Identification of Surfactin Producing Bacillus sp. MB199
The analysis of the 16S rRNA gene sequence (GeneBank
accession no. HM212413) revealed that MB199 was similar to
B. amyloliquefaciens NBRC 15535
T (similarity, 100%/1472 bps,
based on 16S rRNA) (Fig. 4). Through the alignment and cladistic
analysis of homologous nucleotide sequences of known Bacillus,
phylogenetic relationships could be inferred. The approximate
phylogenetic position of the strain is shown in Fig. 4. According to
the gene sequence, the strain Bacillus sp. MB199 was identified as a
strain of B. amyloliquefaciens, and named B. amyloliquefaciens MB199.
The selection of high amounts of surfactin producing strains is
necessary for future mutation or bioengineering studies. Previous-
ly, our laboratory has constructed a high quality marine microbial
natural product library containing novel microorganisms from
marine environments. In this study, B. amyloliquefaciens was
discovered to an efficient C15-surfactin producer from four Bacillus
species. Actually, a recent report revealed that B. amyloliquefaciens is
a producer of both lipopeptide and polyketide antibiotics [33].
These studies proved that B. amyloliquefaciens could be a promising
strain used for the C15-surfactin production in the further
engineering studies.
Optimization of C15-surfactin Production by PBD
The importance of the eight parameters, namely, sucrose,
NH4NO3,K 2HPO4?3H2O, NaH2PO4?2H2O, MgSO4?7H2O,
MnCl2?4H2O, yeast extract and temperature for C15-surfactin
production was investigated by PBD. Table 1 shows the effects of
these parameters on the response along with significant levels.
Based on the statistical analysis, the parameters that significantly
(confidence level .95%) affected the C15-surfactin production
were sucrose, NH4NO3, and NaH2PO4?2H2O with coefficients of
(2) 9.98, (+) 8.07, and (+) 8.55, respectively. Other factors had no
obvious effects and the low confidence levels indicating insignif-
icant influence on the yield of C15-surfactin. With these significant
parameters, the R
2 was found to be 0.9625, which indicated the
model could explain 96.25% of the total variations in the system.
Optimization by the Path of Steepest Ascent Experiment
PBD results indicated that the effect of sucrose was negative,
whereas those like NH4NO3 and NaH2PO4?2H2O were positive.
Thus, decreasing sucrose concentration and increasing concen-
trations of NH4NO3 and NaH2PO4?2H2O should result in a
higher production of C15-surfactin. For each of these factors, the
average values from the PBD experiments were used as initial
points for the path of steepest ascent experiments, and the
concentrations were either increased or decreased as indicated by
the PBD experiments. It showed the maximum production of C15-
surfactin (124.1863.53 mg/L) (Table 5). This was obtained when
the parameters were 20 g/L sucrose, 2 g/L NH4NO3 and 10 g/L
Table 5. Design and results of path of steepest ascent
experiment.
Run Factor
Yield of C15-
surfactin (mg/
L)
X1 (g/L)
a X2 (g/L) X3 (g/L)
1 23 1.54 6.2 71.90611.53
2 20 2 10 124.1863.53
3 17 2.46 13.8 103.7161.61
4 14 2.92 17.6 101.7567.68
aX1,X 2 and X3 represent Sucrose, NH4NO3 and NaH2PO4N2H2O, respectively.
doi:10.1371/journal.pone.0034430.t005
Table 6. Regression coefficients and their significance for
response surface model.
Term Coef Standard Error P
Intercept 120.62 2.63 ,0.0001
X1
a 25.54 1.75 0.0099
X2 12.04 1.75 ,0.0001
X3 15.40 1.75 ,0.0001
X1*X1 21.64 1.70 0.3576
X2*X2 22.48 1.70 0.1749
X3*X3 216.43 1.70 ,0.0001
X1*X2 6.62 2.28 0.0159
X1*X3 5.30 2.28 0.0427
X2*X3 24.95 2.28 0.0554
aX1,X 2 and X3 represent Sucrose, NH4NO3 and NaH2PO4N2H2O, respectively.
doi:10.1371/journal.pone.0034430.t006
Table 7. ANOVA of regression model.
Source DF
1 Seq SS
2 Adj MS
3 FP
Regression 9 10310.53 1145.61 27.48 ,0.0001
Pure error 5 88.64 17.73
Lack of fit 5 328.26 65.65 3.70 0.0886
Total 19 10727.43
Determination of coefficient R
2=0.9611; adjusted determination coefficient Adj
R
2=0.9262.
1DF, Degree of freedom;
2SS, sum of squares;
3MS, mean square.
doi:10.1371/journal.pone.0034430.t007
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doi:10.1371/journal.pone.0034430.g005
Figure 6. HPLC profile of surfactin produced by B. amyloliquefaciens MB199. The elution was monitored at 210 nm at a flow rate of 1 mL/
min. The dashed line and the real line represent the HPLC profiles of surfactins produced in optimized and original culture media, respectively.
doi:10.1371/journal.pone.0034430.g006
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Optimization by Response Surface Methodology
The data shown in Table 3 were analyzed using Design Expert
software. The t-test and P-values were used to identify the effect of
each factor on C15-surfactin production (Table 6), with a P-value
of less than 0.05 indicating significance. Sucrose, NH4NO3 and
NaH2PO4?2H2O had significant effects on C15-surfactin yield
(P,0.05) and were able to explain 96.11% of the model
variability. Therefore, the present prediction model reflected a
good degree of correlation between the observed and predicted
responses, implying the model was reliable for C15-surfactin
production in the present study. The adjusted determination
coefficient (R
2=86.25%) was also satisfactory to confirm the
significance of the model. The model can be shown as following:
Y~120:62{5:54X1z12:04X2z15:40X3
{16:43X3   X3z6:62X1   X2z5:30 X1   X3
ð1Þ
Where Y is the predicted C15-surfactin yield, X1 is sucrose, X2 is
NH4NO3, and X3 is NaH2PO4?2H2O.
Furthermore, the ANOVA analysis for the response surface
quadratic model was presented in Table 7, which reported a
statistically significant (P,0.05) regression at a 95% confidence
level. To check the fitness of the polynomial model, the significant
lack-of-fit was also reported in Table 7, which means there is some
variation unaccounted for in the predicted model (the selected
model does not well describe the data). In this study, P=0.0886
indicated that the model was statistically insignificant lack of fit, so
it was adequate for the prediction of C15-surfactin yield within the
range of variables tested. The 3D response surface graphs provide
a more complete representation of the effects of variables on the
production of C15-surfactin (Fig. 5).
Validation of the Optimized Condition
On the basis of medium optimization, the model predicted the
maximum production of surfactin as132.61 mg/L, in the presence
of 21.17 g/L sucrose, 2.50 g/L NH4NO3, and 11.56 g/L
NaH2PO4?2H2O. To verify the predicted results, a validation
experiment was performed in triplicate tests. Under the optimized
condition, the observed experimental yield of average C15-
surfactin was 134.2 mg/L, which is a 1.52-fold increase as
compared to the yield in non-optimized media, suggesting that
experimental and predicted values of C15-surfactin yield were in
good agreement. This result therefore corroborated the predicted
values and the effectiveness of the model, indicating that the
optimized medium favors the production of C15-surfactin.
Actually, the pH value of the culture medium also has an effect
on surfactin production. Surfactins have emulsification activities,
so we use the emulsification index (EU/mL) as a parameter to
evaluate the production of surfactins in cell broth. Our previous
data showed that the production of surfactin will decrease in a
culture medium with a pH less than 5 or larger than 9 [21]. In the
present work, a pH of 7.2 was used throughout the optimization
experiment. Noteworthy, the data on growth of Bacillus amyloli-
quefaciens was not measured in the present optimization experi-
ment, so there was no information on the ‘‘specific productivity’’ of
C15-surfactin by Bacillus amyloliquefaciens. However, a recent thesis
showed that surfactin productivity was cell growth associated for
Bacillus subtilis ATCC 21332 [34].
In the literature, a medium containing glucose (10.0 g/L) and
ammonium nitrate (4.0 g/L) could lead to the highest quantity of
surfactins (439.0 mg/L) by B. subtilis ATCC 21332 [35]. However,
C15-surfactin was not clearly reported in these experiments due to
the different analysis methods. Our present study focused on C15-
surfactin production not only due to its effective biological
activities, but also because purification of this compound was
relatively easy by using HPLC (Fig. 6). In this respect, the present
study was useful for the further investigations of the industrial
production of C15-surfactin. Additionally, it has been found that
surfactin producing B. subtilis strain S499 could produce a novel
lipopeptide fengycin after the optimization of medium composi-
tion for the surfactin production [36]. In order to find out how the
culture medium components influence the production of the other
homologues of C15-surfactin, the HPLC profile of surfactins of
B. amyloliquefaciens MB199 was measured. The results showed an
increase in the yield of other homologues of C15-surfactin without
influencing the diversity of the surfactins produced in the cell broth
(Fig. 6).
In conclusion, the present work shows that C15-surfactin as a
biomaterial could be utilized as a synergistic antifungal agent with
ketoconazole for novel applications in biomedical and pharma-
ceutical fields. This study also offered a novel marine derived B.
amyloliquefaciens strain MB199 which could efficiently produce C15-
surfactin in shaker flasks. It showed that sucrose as a soluble
carbon source and ammonium nitrate as a nitrogen source gave
higher C15-surfactin production. The production of C15-surfactin
was found to depend greatly on the key media components that
were sucrose, ammonium nitrate, and NaH2PO4?2H2O. Using the
RSM, it was possible to model individual and interactive effects of
media and efficiently enhance the production of C15-surfactin.
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